The Analyst · 2012 · 117 citations · 20 references
EngineeringBioengineeringOncologyBiosensorsImmunotechnologyMolecular DiagnosticsCancer BiomarkersEnzyme-linked Immunosorbent AssayNanomaterial-based BiosensorsNanoparticle-based ImmunotechnologyNanosensorsTumor MarkersCancer Biomarker DetectionEnzyme-linked Immunosorbent Assay (Elisa)Lower Limit Of QuantificationLower Limit Of QuantitationMethod Detection LimitNanomaterial-based ImmunosensorsNanoparticle-based ImmunoassaysTumor Marker Assays
The availability of techniques for the sensitive detection of early stage cancer is crucial for patient survival. Our previous research (Langmuir, 2011, 27, 2155-2158) showed that gold nanoparticle layers (GNPL) used in indirect format ELISA amplified the signal, and gave a lower limit of detection (LOD) compared with commercial ELISA plates. However, due to its intrinsic limitations, indirect ELISA is not suitable for samples of complex composition, such as serum, plasma, etc., thus limiting the clinical performance of this kind of ELISA. In the work reported here, a GNPL-based sandwich format ELISA was developed, which showed superiority in terms of detection limit and sensitivity in the determination of rabbit IgG in buffer. More importantly, experiments using plasma spiked with carcinoembryonic antigen (CEA) as a representative biomarker showed that our GNPL-based ELISA assay amplified the signal and lowered the LOD compared to other assays, including commercialized CEA ELISA kits. This simple and cost-effective GNPL-based sandwich ELISA holds promise in clinical applications.
20
Chao‐Min Cheng, Andres W. Martinez, Jinlong Gong et al. · Angewandte Chemie International Edition · 2010 · 705 citations · Full text
Nanotechnology for Early Cancer Detection
Youngeun Choi, Ju‐Won Kwak, Joon Won Park · Sensors · 2010 · 322 citations · Full text
Nano-ELISA for highly sensitive protein detection
Chun-Ping Jia, Xiao-Qin Zhong, Mei‐Ying Liu et al. · Biosensors and Bioelectronics · 2009 · 167 citations